These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
311 related articles for article (PubMed ID: 35577782)
21. Cannabidiol Induces Rapid and Sustained Antidepressant-Like Effects Through Increased BDNF Signaling and Synaptogenesis in the Prefrontal Cortex. Sales AJ; Fogaça MV; Sartim AG; Pereira VS; Wegener G; Guimarães FS; Joca SRL Mol Neurobiol; 2019 Feb; 56(2):1070-1081. PubMed ID: 29869197 [TBL] [Abstract][Full Text] [Related]
22. Isoflurane produces antidepressant effects inducing BDNF-TrkB signaling in CUMS mice. Zhang SS; Tian YH; Jin SJ; Wang WC; Zhao JX; Si XM; Zhang L; Xu H; Jin JY Psychopharmacology (Berl); 2019 Nov; 236(11):3301-3315. PubMed ID: 31197433 [TBL] [Abstract][Full Text] [Related]
23. Activity-Dependent Brain-Derived Neurotrophic Factor Release Is Required for the Rapid Antidepressant Actions of Scopolamine. Ghosal S; Bang E; Yue W; Hare BD; Lepack AE; Girgenti MJ; Duman RS Biol Psychiatry; 2018 Jan; 83(1):29-37. PubMed ID: 28751069 [TBL] [Abstract][Full Text] [Related]
24. Essential roles of neuropeptide VGF regulated TrkB/mTOR/BICC1 signaling and phosphorylation of AMPA receptor subunit GluA1 in the rapid antidepressant-like actions of ketamine in mice. Shen M; Lv D; Liu X; Li S; Chen Y; Zhang Y; Wang Z; Wang C Brain Res Bull; 2018 Oct; 143():58-65. PubMed ID: 30316917 [TBL] [Abstract][Full Text] [Related]
25. VGF and its C-terminal peptide TLQP-62 in ventromedial prefrontal cortex regulate depression-related behaviors and the response to ketamine. Jiang C; Lin WJ; Labonté B; Tamminga CA; Turecki G; Nestler EJ; Russo SJ; Salton SR Neuropsychopharmacology; 2019 Apr; 44(5):971-981. PubMed ID: 30504797 [TBL] [Abstract][Full Text] [Related]
26. Role of 5-HT1A Receptor Stimulation in the Medial Prefrontal Cortex in the Sustained Antidepressant Effects of Ketamine. Fukumoto K; Iijima M; Funakoshi T; Chaki S Int J Neuropsychopharmacol; 2018 Apr; 21(4):371-381. PubMed ID: 29309585 [TBL] [Abstract][Full Text] [Related]
28. Comparison of R-ketamine and rapastinel antidepressant effects in the social defeat stress model of depression. Yang B; Zhang JC; Han M; Yao W; Yang C; Ren Q; Ma M; Chen QX; Hashimoto K Psychopharmacology (Berl); 2016 Oct; 233(19-20):3647-57. PubMed ID: 27488193 [TBL] [Abstract][Full Text] [Related]
30. Optogenetic stimulation of medial prefrontal cortex Drd1 neurons produces rapid and long-lasting antidepressant effects. Hare BD; Shinohara R; Liu RJ; Pothula S; DiLeone RJ; Duman RS Nat Commun; 2019 Jan; 10(1):223. PubMed ID: 30644390 [TBL] [Abstract][Full Text] [Related]
31. [Resolvin E1 as a potential lead for the treatment of depression]. Deyama S; Minami M; Kaneda K Nihon Yakurigaku Zasshi; 2024; 159(4):210-213. PubMed ID: 38945902 [TBL] [Abstract][Full Text] [Related]
32. Activation of a ventral hippocampus-medial prefrontal cortex pathway is both necessary and sufficient for an antidepressant response to ketamine. Carreno FR; Donegan JJ; Boley AM; Shah A; DeGuzman M; Frazer A; Lodge DJ Mol Psychiatry; 2016 Sep; 21(9):1298-308. PubMed ID: 26619811 [TBL] [Abstract][Full Text] [Related]
33. Comparison of ketamine, 7,8-dihydroxyflavone, and ANA-12 antidepressant effects in the social defeat stress model of depression. Zhang JC; Yao W; Dong C; Yang C; Ren Q; Ma M; Han M; Hashimoto K Psychopharmacology (Berl); 2015 Dec; 232(23):4325-35. PubMed ID: 26337614 [TBL] [Abstract][Full Text] [Related]
34. The antidepressant-like effects of glutamatergic drugs ketamine and AMPA receptor potentiator LY 451646 are preserved in bdnf⁺/⁻ heterozygous null mice. Lindholm JS; Autio H; Vesa L; Antila H; Lindemann L; Hoener MC; Skolnick P; Rantamäki T; Castrén E Neuropharmacology; 2012 Jan; 62(1):391-7. PubMed ID: 21867718 [TBL] [Abstract][Full Text] [Related]
36. Sex differences in the rapid and the sustained antidepressant-like effects of ketamine in stress-naïve and "depressed" mice exposed to chronic mild stress. Franceschelli A; Sens J; Herchick S; Thelen C; Pitychoutis PM Neuroscience; 2015 Apr; 290():49-60. PubMed ID: 25595985 [TBL] [Abstract][Full Text] [Related]
37. TAK-653, an AMPA receptor potentiator with minimal agonistic activity, produces an antidepressant-like effect with a favorable safety profile in rats. Hara H; Suzuki A; Kunugi A; Tajima Y; Yamada R; Kimura H Pharmacol Biochem Behav; 2021 Dec; 211():173289. PubMed ID: 34655652 [TBL] [Abstract][Full Text] [Related]
38. Decreased efficacy of the ketamine and scopolamine-induced sustained antidepressant-like effects in rats receiving metformin. Chuang HW; Wei IH; Li CT; Huang CC Pharmacol Rep; 2022 Apr; 74(2):340-352. PubMed ID: 34850372 [TBL] [Abstract][Full Text] [Related]
39. Rapid-acting and long-lasting antidepressant-like action of (R)-ketamine in Nrf2 knock-out mice: a role of TrkB signaling. Qu Y; Shan J; Wang S; Chang L; Pu Y; Wang X; Tan Y; Yamamoto M; Hashimoto K Eur Arch Psychiatry Clin Neurosci; 2021 Apr; 271(3):439-446. PubMed ID: 33180200 [TBL] [Abstract][Full Text] [Related]
40. Ketamine treatment involves medial prefrontal cortex serotonin to induce a rapid antidepressant-like activity in BALB/cJ mice. Pham TH; Mendez-David I; Defaix C; Guiard BP; Tritschler L; David DJ; Gardier AM Neuropharmacology; 2017 Jan; 112(Pt A):198-209. PubMed ID: 27211253 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]